We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 15,852

The pitfalls of incorporation by reference and numerous arguments in inter partes review

  • Baker Botts LLP
  • -
  • USA
  • -
  • November 1 2014

The Leahy-Smith American Invents Act provides post-grant procedures for challenging the validity of a granted patent before a panel of administrative

Death of the 'starting point' approach: AstraZeneca v Apotex

  • Shelston IP
  • -
  • Australia
  • -
  • October 29 2014

A recent decision of the Full Court of the Federal Court of Australia, AstraZeneca AB v Apotex Pty Ltd (2014) 312 ALR 1 ('AstraZeneca') has clarified

Inventorship in heat tracing cable combination invention cannot be traced to those who merely suggest individual elements

  • SIM. IP Practice
  • -
  • Canada
  • -
  • October 29 2014

On September 16, 2014, the Federal Court delivered its decision in Drexan, in which an application to add the inventors, Steve Makar and Konrad Mech

Federal Circuit upholds ITC’s authority to enforce consent order covering third-party products

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

The U.S. Court of Appeals for the Federal Circuit affirmed in part and reversed in part a decision of the International Trade Commission (ITC, the

“Removed” versus “removable” controls infringement inquiry

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

Addressing a district court’s summary judgment of infringement, the U.S. Court of Appeals for the Federal Circuit affirmed the district court’s

Choose your battles before the PTAB 49 basis is just too many!

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

In a combined decision of three Inter Partes Review (IPR) proceedings issued by the Patent Trial and Appeal Board (PTAB or Board), the Board declined

Post-Therasense: Federal Circuit divided on inequitable conduct

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

In a post-Therasense decision, addressing the issue of inequitable conduct the U.S. Court of Appeals for the Federal Circuit upheld a district court’s

Federal Circuit clarifies damages issues in vacating a $386 million patent infringement verdict

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

In a decision addressing two important damages issues, the U.S. Court of Appeals for the Federal Circuit vacated a $386 million patent infringement

PTAB designates seven recent decisions as informative

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

The Patent Trial and Appeal Board (PTAB) recently designated seven decisions from Inter Partes Review (IPR) proceedings as informative opinions: ZTE

The Federal Circuit denies interlocutory appeal in licensing dispute

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 29 2014

Addressing a petition to take an interlocutory appeal stemming from a contract dispute, the U.S. Court of Appeals for the Federal Circuit exercised